Do antidepressants make children and adolescents suicidal?

Journal of Paediatrics and Child Health

Volumn 50, Issue 11, 2014, Pages 847-854

  Gordon, Michael S ^a   Melvin, Glenn A ^b  

^a MONASH MEDICAL CENTRE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

adolescent; antidepressive agent; review; suicide

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CITALOPRAM; FLUOXETINE; FLUVOXAMINE; MIRTAZAPINE; NEFAZODONE; PAROXETINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

ADOLESCENT; AUTOPSY; BLACK BOX WARNIN; COMPARATIVE EFFECTIVENESS; CONTROLLED CLINICAL TRIAL (TOPIC); DEPRESSION; DRUG INFORMATION; DRUG LABELING; DRUG SAFETY; DRUG USE; EVIDENCE BASED MEDICINE; FOOD AND DRUG ADMINISTRATION; HUMAN; META ANALYSIS; NOTE; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL; RISK FACTOR; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; CHILD; CHILD WELFARE; FEMALE; INCIDENCE; LEGISLATION AND JURISPRUDENCE; MALE; PATIENT SAFETY; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; STATISTICS AND NUMERICAL DATA; SUICIDE ATTEMPT; UNITED STATES;

ADOLESCENT; ANTIDEPRESSIVE AGENTS; CHILD; CHILD WELFARE; DRUG LABELING; FEMALE; HUMANS; INCIDENCE; MALE; PATIENT SAFETY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; SUICIDAL IDEATION; SUICIDE, ATTEMPTED; UNITED STATES;

EID: 84936774636     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/jpc.12655     Document Type: Note

References (59)

1. Cheung AH, Zuckerbrot RA, Jensen PS, et al. Guidelines for adolescent depression in primary care (GLAD-PC): II. Treatment and ongoing management. Pediatrics 2007; 120: e1313-1326.
2. beyondblue. Clinical Practice Guidelines: Depression in Children and Young Adults. Melbourne: beyondblue: The National Depression Initiative, 2010.
3. National Institute for Health and Clinical Excellence NICE. Depression in Children and Young People: Identification and Management in Primary, Community and Secondary Care. Leicester, UK: British Psychological Society, 2005. Available from: http://www.nice.org.uk/CG028.
4. King RA, Riddle MA, Chappell PB, et al. Emergence of self-destructive phenomena in children and adolescents during fluoxetine treatment. J. Am. Acad. Child Adolesc. Psychiatry 1991; 30: 179-186.
5. Mann JJ, Emslie G, Baldessarini RJ, et al. ACNP Task Force report on SSRIs and suicidal behavior in youth. Neuropsychopharmacology 2006; 31: 473-492.
6. Hammad TA,. Review and Evaluation of Clinical Data. TGA, 2004. Available from: http://www.fda.gov/ohrms/dockets/ac/04/briefing/2004-4065b1-10-TAB08-Hammads-Review.pdf [accessed December 2013].
7. FDA. Labeling Change Request Letter for Antidepressant Medications. FDA, 2004. Black box warning of antidepressant medication in children and adolescents]. Available from: http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm096352.htm [accessed 12 December 2013].
8. Licinio J, Wong ML,. Depression, antidepressants and suicidality: a critical appraisal. Nat. Rev. Drug Discov. 2005; 4: 165-171.
9. RANZCP RACGP RACP. Clinical Guidance on the Use of Antidepressant Medication by Children and Adolescents. RANZCP RACGP RACP, 2005. Available from: http://www.ranzcp.org/Files/ranzcp-attachments/Resources/College-Statements/Practice-Guidelines/Clinical-Guidance-on-the-use-of-Antidepressant-med.aspx [accessed April 2013].
10. FDA. FDA Proposes New Warnings About Suicidal Thinking, Behavior in Young Adults Who Take Antidepressant Medications. Silver Spring, Maryland: FDA, 2007. Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm108905.htm [accessed April 2013].
11. Libby AM, Brent DA, Morrato EH, Orton HD, Allen R, Valuck RJ,. Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs. Am. J. Psychiatry 2007; 164: 884-891.
12. Cheung A, Sacks D, Dewa CS, Pong J, Levitt A,. Pediatric prescribing practices and the FDA black-box warning on antidepressants. J. Dev. Behav. Pediatr. 2008; 29: 213-215.
13. Whittington CJ, Kendall T, Fonagy P, Cottrell D, Cotgrove A, Boddington E,. Selective serotonin reuptake inhibitors in childhood depression: systematic review of published verses unpublished data. Lancet 2004; 363: 1341-1345.
14. Mosholder AD, Willy M,. Suicidal adverse events in pediatric randomized, controlled clinical trials of antidepressant drugs are associated with active drug treatment: a meta-analysis. J. Child Adolesc. Psychopharmacol. 2006; 16: 25-32.
15. Hammad TA, Laughren T, Racoosin J,. Suicidality in pediatric patients treated with antidepressant drugs. Arch. Gen. Psychiatry 2006; 63: 332-339.
16. Wohlfarth TD, van Zwieten BJ, Lekkerkerker FJ, et al. Antidepressants use in children and adolescents and the risk of suicide. Eur. Neuropsychopharmacol. 2006; 16: 79-83.
17. March JS, Klee BJ, Kremer CM,. Treatment benefit and the risk of suicidality in multicenter, randomized, controlled trials of sertraline in children and adolescents. J. Child Adolesc. Psychopharmacol. 2006; 16: 91-102.
18. Kaizar EE, Greenhouse JB, Seltman H, Kelleher K,. Do antidepressants cause suicidality in children? A Bayesian meta-analysis. Clin. Trials 2006; 3: 73-98.
19. Dubicka B, Hadley S, Roberts C,. Suicidal behaviour in youths with depression treated with new-generation antidepressants: meta-analysis. Br. J. Psychiatry 2006; 189: 393-398.
20. Bridge JA, Iyengar S, Salary CB, et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA 2007; 297: 1683-1696.
21. Hetrick SE, McKenzie JE, Merry SN,. The use of SSRIs in children and adolescents. Curr. Opin. Psychiatry 2010; 23: 53-57.
22. Hetrick SE, McKenzie JE, Cox GR, Simmons MB, Merry SN,. Newer generation antidepressants for depressive disorders in children and adolescents. Cochrane Database Syst. Rev. 2012; 11: CD004851.
23. Julious SA,. Efficacy and suicidal risk for antidepressants in paediatric and adolescent patients. Stat. Methods Med. Res. 2013; 22: 190-218.
24. Hall WD, Lucke J,. How have the selective serotonin reuptake inhibitor antidepressants affected suicide mortality? Aust. N. Z. J. Psychiatry 2006; 40: 941-950.
25. Olfson M, Shaffer D, Marcus SC, Greenberg T,. Relationship between antidepressant medication treatment and suicide in adolescents. Arch. Gen. Psychiatry 2003; 60: 978-982.
26. Gibbons RD, Hur K, Bhaumik DK, Mann JJ,. The relationship between antidepressant medication use and rate of suicide. Arch. Gen. Psychiatry 2005; 62: 165-172.
27. Gibbons RD, Hur K, Bhaumik DK, Mann JJ,. The relationship between antidepressant prescription rates and rate of early adolescent suicide. Am. J. Psychiatry 2006; 163: 1898-1904.
28. Gibbons RD, Brown CH, Hur K, et al. Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents. Am. J. Psychiatry 2007; 164: 1356-1363.
29. Jick H, Kaye JA, Jick SS,. Antidepressants and the risk of suicidal behaviors. JAMA 2004; 292: 338-343.
30. Olfson M, Marcus SC, Shaffer D,. Antidepressant drug therapy and suicide in severely depressed children and adults: a case-control study. Arch. Gen. Psychiatry 2006; 63: 865-872.
31. Søndergård L, Kvist K, Andersen PK, Kessing LV,. Do antidepressants precipitate youth suicide? Eur. Child Adolesc. Psychiatry 2006; 15: 232-240.
32. Tiihonen J, Lonnqvist J, Wahlbeck K, Klaukka T, Tanskanen A, Haukka J,. Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort. Arch. Gen. Psychiatry 2006; 63: 1358-1367.
33. Simon GE, Savarino J, Operkalski B, Wang PS,. Suicidal risk during antidepressant treatment. Am. J. Psychiatry 2006; 163: 41-47.
34. Valuck RJ, Libby AM, Sills MR, Giese AA, Allen RR,. Antidepressant treatment and risk of suicide attempt by adolescents with major depressive disorder: a propensity-adjusted retrospective cohort study. CNS Drugs 2004; 18: 1119-1132.
35. Martinez C, Rietbrock S, Wise L, et al. Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study. BMJ 2005; 330: 389.
36. Simon GE, Savarino J,. Suicide attempts among patients starting depression treatment with medications or psychotherapy. Am. J. Psychiatry 2007; 164: 1029-1034.
37. Olfson M, Marcus SC,. A case-control study of antidepressants and attempted suicide during early phase treatment of major depressive episodes. J. Clin. Psychiatry 2008; 69: 425-432.
38. Valuck RJ, Orton HD, Libby AM,. Antidepressant discontinuation and risk of suicide attempt: a retrospective, nested case-control study. J. Clin. Psychiatry 2009; 70: 1069-1077.
39. Schneeweiss S, Patrick AR, Solomon DH, et al. Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts. Pediatrics 2010; 125: 876-888.
40. Hysinger EB, Callahan ST, Caples TL, Fuchs DC, Shelton RC, Cooper WO,. Suicidal behavior differs among early and late adolescents treated with antidepressant agents. Pediatrics 2011; 128: 447-454.
41. Barbui C, Esposito E, Cipriani A,. Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies. CMAJ 2009; 180: 291-297.
42. Isacsson G, Holmgren P, Ahlner J,. Selective serotonin reuptake inhibitor antidepressants and the risk of suicide: a controlled forensic database study of 14,857 suicides. Acta Psychiatr. Scand. 2005; 111: 286-290.
43. Leon AC, Marzuk PM, Tardiff K, Teres JJ,. Paroxetine, other antidepressants, and youth suicide in New York City: 1993 through 1998. J. Clin. Psychiatry 2004; 65: 915-918.
44. Leon AC, Marzuk PM, Tardiff K, Bucciarelli A, Markham Piper T, Galea S,. Antidepressants and youth suicide in New York City, 1999-2002. J. Am. Acad. Child Adolesc. Psychiatry 2006; 45: 1054-1058.
45. Singh VD, Lathrop SL,. Youth suicide in New Mexico: a 26-year retrospective review. J. Forensic Sci. 2008; 53: 703-708.
46. Moskos M, Olson L, Halbern S, Keller T, Gray D,. Utah youth suicide study: psychological autopsy. Suicide Life Threat. Behav. 2005; 35: 536-546.
47. Cortes E, Cubano A, Lewis JE, Castellanos D,. Antidepressants at autopsy in hispanic suicidal youth in Miami-Dade County, Florida. J. Forensic Sci. 2011; 56: 155-160.
48. Emslie GJ, Ryan ND, Wagner KD,. Major depressive disorder in children and adolescents: clinical trial design and antidepressant efficacy. J. Clin. Psychiatry 2005; 66: 14-20.
49. Greenhouse JB, Kaizar EE, Kelleher K, Seltman H, Gardner W,. Generalizing from clinical trial data: a case study. The risk of suicidality among pediatric antidepressant users. Stat. Med. 2008; 27: 1801-1813.
50. Gibbons RD, Brown CH, Hur K, Davis J, Mann JJ,. Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine. Arch. Gen. Psychiatry 2012; 69: 580-587.
51. Baldessarini RJ, Pompili M, Tondo L,. Suicidal risk in antidepressant drug trials. Arch. Gen. Psychiatry 2006; 63: 246-248.
52. Cox G, Callahan P, Churchill R, et al. Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents (review). Cochrane Database Syst. Rev. 2012; 11: CD008324.
53. Gibbons R, Mann JJ,. Proper studies of selective serotonin reuptake inhibitors are needed for youth with depression. CMAJ 2009; 180: 270-271.
54. Grimsley SR, Jann MW,. Paroxetine, sertraline, and fluvoxamine: new selective serotonin reuptake inhibitors. Clin. Pharm. 1992; 11: 930-957.
55. Isacsson G, Rich CL, Jureidini J, Raven M,. The increased use of antidepressants has contributed to the worldwide reduction in suicide rates. Br. J. Psychiatry 2010; 196: 429-433.
56. Kuba T, Yakushi T, Fukuhara H, et al. Suicide-related events among child and adolescent patients during short-term antidepressant therapy. Psychiatry Clin. Neurosci. 2011; 65: 239-245.
57. Hetrick S, Simmons M, Merry S,. SSRIs and depression in children and adolescents: the imperative for shared decision-making. Australas. Psychiatry 2008; 16: 354-358.
58. Teicher MH, Glod CA, Cole JO,. Antidepressant drugs and the emergence of suicidal tendencies. Drug Saf. 1993; 8: 186-212.
59. Gordon M, Melvin G,. Selective serotonin re-uptake inhibitors-a review of the side effects in adolescents. Aust. Fam. Physician 2013; 42: 620-623.